Thyrocare Technologies Ltd
NSE:THYROCARE

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
NSE:THYROCARE
Watchlist
Price: 915.1 INR 0.36%
Market Cap: 48.5B INR
Have any thoughts about
Thyrocare Technologies Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one THYROCARE stock under the Base Case scenario is 982.34 INR. Compared to the current market price of 915.1 INR, Thyrocare Technologies Ltd is Undervalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

THYROCARE Relative Value
Base Case
982.34 INR
Undervaluation 7%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.8
P/S
P/S
Price to Sales
7.8
vs History
30
vs Industry
22
Median 3Y
6.1
Median 5Y
6.5
Industry
2.3
Forward
7.1
More Details
57.7
P/E
P/E
Price to Earnings
57.7
vs History
7
vs Industry
9
Median 3Y
44.4
Median 5Y
41.3
Industry
23.2
Forward
49
More Details
25.9
P/OCF
P/OCF
Price to OCF
25.9
vs History
44
vs Industry
20
Median 3Y
26.1
Median 5Y
26.2
Industry
14.3
More Details
37
P/FCFE
P/FCFE
Price to FCFE
37
vs History
52
vs Industry
19
Median 3Y
39.8
Median 5Y
40.4
Industry
20.1
More Details
9.9
P/B
P/B
Price to Book Value
9.9
vs History
23
vs Industry
11
Median 3Y
6.5
Median 5Y
7.3
Industry
2.2
More Details
7.6
EV/S
EV/S
Enterprise Value to Sales
7.6
vs History
30
vs Industry
20
Median 3Y
5.9
Median 5Y
6.4
Industry
2.4
Forward
6.9
More Details
10.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.7
vs History
30
vs Industry
26
Median 3Y
8.2
Median 5Y
8.9
Industry
5
More Details
30.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.2
vs History
4
vs Industry
13
Median 3Y
22.5
Median 5Y
22.8
Industry
12.8
Forward
27.2
More Details
44.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
44.7
vs History
4
vs Industry
10
Median 3Y
33
Median 5Y
32.1
Industry
17.2
Forward
38.1
More Details
25.4
EV/OCF
EV/OCF
Enterprise Value to OCF
25.4
vs History
41
vs Industry
21
Median 3Y
25.5
Median 5Y
25.6
Industry
14
More Details
28.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
28.8
vs History
68
vs Industry
15
Median 3Y
40
Median 5Y
40.2
Industry
18.2
More Details
11.3
EV/IC
EV/IC
Enterprise Value to IC
11.3
vs History
15
vs Industry
12
Median 3Y
7.1
Median 5Y
7.3
Industry
1.9
More Details

Multiples Across Competitors

THYROCARE Competitors Multiples
Thyrocare Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Thyrocare Technologies Ltd
NSE:THYROCARE
48.7B INR 7.8 57.7 30.2 44.7
US
Cigna Group
XMUN:CGN
75B EUR 0.3 25.7 8 10.4
US
Cigna Corp
NYSE:CI
77.2B USD 0.3 25.4 8 10.3
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.9B EUR 1.3 39.2 10.7 23.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.3 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2B USD 1.5 44.1 13.2 20.3
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
16.9B USD 1.8 20.2 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 19.7 6.6 14.3
US
DaVita Inc
NYSE:DVA
12.4B USD 1 14.9 7.8 10.9

See Also

Summary
THYROCARE intrinsic value, competitors valuation, and company profile.
DCF Valuation
THYROCARE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
THYROCARE stock valuation using valuation multiples.
Wall Street Estimates
THYROCARE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
THYROCARE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.